Beta Bionics, Inc.

Beta Bionics, Inc. — FDA 510(k) Submissions

Beta Bionics, Inc. has submitted 5 FDA 510(k) premarket notifications since 2023, of which 5 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Alternate Controller Enabled Insulin Infusion Pump, Interoperable Automated Glycemic Controller . Use the specialty filter in the sidebar to narrow results.